These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31658004)

  • 1. Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research.
    Boltze J; Modo MM; Mays RW; Taguchi A; Jolkkonen J; Savitz SI;
    Stroke; 2019 Nov; 50(11):3299-3306. PubMed ID: 31658004
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models of ischemic stroke and their application in clinical research.
    Fluri F; Schuhmann MK; Kleinschnitz C
    Drug Des Devel Ther; 2015; 9():3445-54. PubMed ID: 26170628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis and Systematic Review of Neural Stem Cells therapy for experimental ischemia stroke in preclinical studies.
    Chen L; Zhang G; Gu Y; Guo X
    Sci Rep; 2016 Aug; 6():32291. PubMed ID: 27554433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke drug development: usually, but not always, animal models.
    Donnan GA; Davis SM
    Stroke; 2005 Oct; 36(10):2326. PubMed ID: 16141427
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of animal models has not contributed to development of acute stroke therapies: pro.
    Kaste M
    Stroke; 2005 Oct; 36(10):2323-4. PubMed ID: 16141431
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of animal models has not contributed to development of acute stroke therapies: con.
    Fisher M; Tatlisumak T
    Stroke; 2005 Oct; 36(10):2324-5. PubMed ID: 16141429
    [No Abstract]   [Full Text] [Related]  

  • 7. Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.
    Dabrowski A; Robinson TJ; Felling RJ
    Curr Neurol Neurosci Rep; 2019 Feb; 19(1):5. PubMed ID: 30712068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?
    Cui LL; Golubczyk D; Tolppanen AM; Boltze J; Jolkkonen J
    Ann Neurol; 2019 Jul; 86(1):5-16. PubMed ID: 31020699
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology of stroke and stroke-induced retinal ischemia: emerging role of stem cells.
    Muthaian R; Minhas G; Anand A
    J Cell Physiol; 2012 Mar; 227(3):1269-79. PubMed ID: 21989824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade?
    Leong WK; Lewis MD; Koblar SA
    Stem Cells; 2013 Jun; 31(6):1040-3. PubMed ID: 23390084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.
    Mangin G; Kubis N
    Stem Cell Rev Rep; 2019 Apr; 15(2):176-193. PubMed ID: 30443706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sisyphus and translational stroke research.
    Lyden P; Lapchak P
    Sci Transl Med; 2012 Oct; 4(156):156ps20. PubMed ID: 23076354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective for stroke and brain injury research: mechanisms and potential therapeutic targets.
    Chen J; Leak RK; Yang GY
    CNS Neurosci Ther; 2015 Apr; 21(4):301-3. PubMed ID: 25809674
    [No Abstract]   [Full Text] [Related]  

  • 14. The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.
    Heyck M; Bonsack B; Zhang H; Sadanandan N; Cozene B; Kingsbury C; Lee JY; Borlongan CV
    Exp Biol Med (Maywood); 2019 Nov; 244(16):1485-1492. PubMed ID: 31604382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia.
    Shen CC; Lin CH; Yang YC; Chiao MT; Cheng WY; Ko JL
    Curr Neurovasc Res; 2010 Aug; 7(3):167-79. PubMed ID: 20560882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function.
    Huang L; Liu Y; Lu J; Cerqueira B; Misra V; Duong TQ
    Stem Cell Res Ther; 2017 Mar; 8(1):74. PubMed ID: 28330501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke: knowledge and research, challenges and goals. Preface.
    Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():V. PubMed ID: 19342827
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the Post-Stroke Therapeutic Potency of Mesenchymal Multipotent Stromal Cells by Cocultivation With Cortical Neurons: The Role of Crosstalk Between Cells.
    Babenko VA; Silachev DN; Zorova LD; Pevzner IB; Khutornenko AA; Plotnikov EY; Sukhikh GT; Zorov DB
    Stem Cells Transl Med; 2015 Sep; 4(9):1011-20. PubMed ID: 26160961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering risk factors for the effectiveness of translational therapies in brain stroke.
    Gutiérrez-Vargas JA; Cardona-Gómez GP
    J Neurol Sci; 2020 Jan; 408():116547. PubMed ID: 31683050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.
    Gervois P; Wolfs E; Ratajczak J; Dillen Y; Vangansewinkel T; Hilkens P; Bronckaers A; Lambrichts I; Struys T
    Med Res Rev; 2016 Nov; 36(6):1080-1126. PubMed ID: 27439773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.